Filter
1621
Text search:
pharmaceutical
needs
Featured
Recommendations
146
New Publications
426
Language
Document type
No document type
815
Studies & Reports
327
Guidelines
246
Strategic & Response Plan
84
Manuals
81
Fact sheets
21
Training Material
19
Situation Updates
11
Brochures
5
Resource Platforms
5
Infographics
5
Online Courses
2
Countries / Regions
India
66
Kenya
66
Global
66
Ethiopia
64
South Africa
49
Nigeria
41
Western and Central Europe
41
Uganda
37
Sierra Leone
34
Liberia
32
Namibia
25
Ghana
23
Tanzania
23
Rwanda
23
Africa
23
Zambia
22
Malawi
21
Ukraine
21
Nepal
20
Zimbabwe
18
Eastern Europe
18
Syria
16
Bangladesh
16
Latin America and the Carribbean
15
Philippines
14
Lesotho
13
Indonesia
12
Cambodia
11
South–East Asia Region
11
Eswatini/ Swaziland
10
Myanmar / Burma
9
West and Central Africa
8
Botswana
7
Eastern Europe and Central Asia
7
Asia
7
Senegal
6
Congo, Democratic Republic of
6
Cameroon
6
South Sudan
6
East and Southern Africa
6
Venezuela
6
Burkina Faso
5
Haiti
5
Vietnam
5
Guinea
4
Pakistan
4
Germany
4
Papua New Guinea
4
Middle East and North Africa
4
Western Pacific Region
4
Mali
3
Jordan
3
Afghanistan
3
Egypt
3
Thailand
3
China
3
Mozambique
3
Brazil
3
North Macedonia
3
Albania
3
Laos
3
North America
3
United Kingdom
3
USA
2
Iraq
2
Sudan
2
Benin
2
Central African Republic
2
Serbia
2
Fiji
2
Russia
2
Lithuania
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Jamaica
2
Saudi Arabia
1
Niger
1
Somalia
1
Lebanon
1
Chad
1
Malaysia
1
Ireland
1
Peru
1
El Salvador
1
Libya
1
Sri Lanka
1
Armenia
1
Southern Africa
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Romania
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
688
Clinical Guidelines
98
Key Resources
82
Public Health
75
Women & Child Health
37
Pharmacy & Technologies
26
Capacity Building
12
Annual Report MEDBOX
2
Toolboxes
AMR
152
Pharmacy
150
COVID-19
119
HIV
91
Mental Health
88
TB
73
NTDs
48
NCDs
39
Rapid Response
34
Planetary Health
32
Caregiver
31
Conflict
29
Global Health Education
29
Health Financing Toolbox
28
Ebola & Marburg
24
Malaria
14
2.0 Rapid Response
14
Disability
13
Refugee
10
Polio
7
Specific Hazards
7
Natural Hazards
6
Cholera
4
Zika
3
Social Ethics
2
Notable progress has also been made on other key health indicators such as reducing maternal, infant and child deaths and malnutrition, increasing immunization coverage, eliminating infectious diseases such as polio and reducing the incidence of malaria, tuberculosis and diarrhoeal diseases.
But
...
Lancet Infectious Diseases Volume 22, Issue 11e327-e335.
In February, 2022, WHO published new guidelines with six recommendations to update the global public health strategy against schistosomiasis, including expansion of preventive chemotherapy eligibility from the predominant group of school-age
...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi
...
The World Health Organization was requested by Member States to develop a global priority pathogens list (global PPL) of antibiotic-resistant bacteria to help in prioritizing the research and development (R&D) of new and effective antibiotic treatments. To date, the selection of pathogens for R&D ac
...
WHO operational handbook on tuberculosis Module 5: Management of tuberculosis in children and adolescents
recommended
The practical guidance in the operational handbook aims to inform the development or revision of national policies and related implementation guidance on the management of TB in children and adolescents under programmatic circumstances and at different levels of the health system. The operational ha
...
Rwanda’s fourth health sector strategic plan (HSSP4) is meant to provide the health sector with a Strategic Plan that will highlight its commitments and priorities for the coming 6 years. It will be fully integrated in the overall economic development plan of the Government. HSSP4 will fulfill the
...
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib
...
A lot has happened this year. While we continued to tackle the COVID-19 pandemic, we were hit by disease outbreaks and
humanitarian crises. Yet, despite these challenges, we marched on, resolute in resolving critical health systems issues to increase
access to quality healthcare services. To furth
...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f
...
A Focus on the Journey to Self-Reliance for Preventing Child and Maternal Deaths . June 2018
The 2018 Acting on the Call report focuses on 25 countries’ journeys to self-reliance for preventing child and maternal deaths. Self-reliance is a country’s ability to finance and implement solution ...
The 2018 Acting on the Call report focuses on 25 countries’ journeys to self-reliance for preventing child and maternal deaths. Self-reliance is a country’s ability to finance and implement solution ...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de
...
Healthy communities rely on well-functioning ecosystems. They provide clean air, fresh water, medicines and food security. They also limit disease and stabilize the climate. But biodiversity loss is happening at unprecedented rates, impacting human health worldwide, according to a new state of knowl
...
Since the release of the first volume in May 2020, the COVID-19 pandemic has continued to rage around the world. By mid-March, 2021, countries around the globe had reported over 123 million cases—a nearly five-fold increase since this report’s previous volume—and over 2.7 million deaths attrib
...
This paper explores access to water, sanitation, and health in pastoral communities in northern Tanzania. It argues that the concept of gender, used on its own, is not enough to understand the complexities of sanitation, hygiene, water, and health. It explores pastoralists’ views and perspectives
...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector
...
The document contains 2 decision trees, the first short one is to act fast and the second is to design better interventions
French version of "Developing Pharmacy Practice" - WHO/FIP Joint handbook - Ce manuel expose un nouveau paradigme de pratique pharmaceutique. Il a pour but de guider les enseignants en pharmacie pour qu’ils intègrent cette nouvelle pratique pharmaceutique, de former les étudiants
...
The purpose of this guide is to offer recommendations for improving the implementation of non‑pharmacological public health measures during the COVID-19 response and compliance with these measures by population groups in situations of vulnerability. This requires determining the main barriers to i
...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
